Non-Specific Clotting Factor Inhibitor
Coagulation
Description
Sample Type
Plasma (Citrate 2.7ml Blue) x 2
Reference Range
The inhibitor titre is measured in Bethesda units (BU) with 1 BU being defined as the the titre of inhibitor which will inhibit 50% of total FVIII activity.
Turnaround Time
Within 2 weeks
Testing Frequency
weekly or as required
External Notes
PRIOR ARRANGEMENT WITH HAEMATOLOGY SPR AND LABORATORY IS REQUIRED FOR URGENT REQUESTS. FVIII:C LEVEL IS ALSO REQUIRED FOR ANALYSIS OF FVIII INHIBITOR.
References
References Verbruggen B et al (1995). The Nijmegen modification of the bethesda assay for FVIII:C inhibitors: improved specificity and reliability. Thromb Haemost. 73, 247-51
Please note: the above information is subject to change and we endeavour to keep this website up to date wherever necessary.
Your contact for this test
Lee Beckett BSc (Hons) Biomedical Science, MSc Pathological Sciences
Routine Coagulation Scientific Lead & Deputy Laboratory Manager - Northern General Hospital
You are enquiring about
Non-Specific Clotting Factor Inhibitor